Patents Examined by Sreenvasan Padmanabhan
  • Patent number: 7375252
    Abstract: This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: May 20, 2008
    Assignee: AtheroGenics, Inc.
    Inventor: Charles Q. Meng